Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease

Respiratory Investigation

Volumn 54, Issue 6, 2016, Pages 387-396

  Corlateanu, Alexandru ^a   Covantev, Serghei ^a   Mathioudakis, Alexander G ^b   Botnaru, Victor ^a   Siafakas, Nikolaos ^c  

^a STATE UNIVERSITY OF MEDICINE AND PHARMACY NICOLAE TESTEMITANU   (Moldova)

^b ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; METFORMIN; STEROID; VITAMIN D;

AGING; ANEMIA; ARTHRITIS; BONE DENSITY; CACHEXIA; CARDIOVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITIES IN CHRONIC OBSTRUCTIVE LUNG DISEASE INDEX; COMORBIDITY; COMORBIDITY ASSESSMENT; COMORBIDITY OBSTRUCTION DYSPNEA AND PREVIOUS EXACERBATION INDEX; COMORBIDOME; CONGESTIVE HEART FAILURE; COPD SPECIFIC COMORBIDITY TEST; COPDCORI; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DYSPNEA SCORE EOSINOPHILIA CONSOLIDATION ACADEMIA AND ATRIAL FIBRILLATION SCORE; ENDOCRINE DISEASE; FRAGILITY FRACTURE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GOLD SCORE; HELICOBACTER INFECTION; HUMAN; HYPERLACTATEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOXIA; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; METABOLIC SYNDROME X; MUSCLE ATROPHY; MUSCULOSKELETAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON SMALL CELL LUNG CANCER; NORMOCYTIC ANEMIA; OSTEOPOROSIS; PATHOGENESIS; PNEUMONIA; PREVALENCE; PROGNOSIS; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SLEEP DISORDERED BREATHING; SMALL CELL LUNG CANCER; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; DISEASE COURSE; HYPERTENSION, PULMONARY; LUNG NEOPLASMS; MYOCARDIAL ISCHEMIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ARTHRITIS; CACHEXIA; COMORBIDITY; DISEASE PROGRESSION; HYPERTENSION, PULMONARY; LUNG NEOPLASMS; METABOLIC SYNDROME X; MYOCARDIAL ISCHEMIA; OSTEOPOROSIS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84995611713     PISSN: 22125345     EISSN: 22125353     Source Type: Journal    
DOI: 10.1016/j.resinv.2016.07.001     Document Type: Review

References (96)

1. [1] Barnes, P.J., Celli, B.R., Systemic manifestations and comorbidities of COPD. Eur Respir J 33 (2009), 1165–1185 PubMed PMID: 19407051.
2. [2] Barnes, N., Calverley, P.M., Kaplan, A., Rabe, K.F., Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey. BMC Pulm Med, 13, 2013, 54 54. PubMed PMID: 23971625. Pubmed Central PMCID: PMC3765923.
3. [3] Corlateanu, A., Montanari, G., Mathioudakis, A., Botnaru, V., Siafakas, N., Management of stable COPD: an update. Curr Respir Med Rev 9 (2013), 352–359.
4. [4] Fumagalli, G., Fabiani, F., Forte, S., et al. INDACO project: COPD and link between comorbidities, lung function and inhalation therapy. Multidiscip Respir Med, 10, 2015, 4 PubMed PMID: 25973198. Pubmed Central PMCID: PMC4429936.
5. [5] Ajmera, M., Sambamoorthi, U., Metzger, A., et al. Multimorbidity and COPD medication receipt among medicaid beneficiaries with newly diagnosed COPD. Respir Care 60 (2015), 1592–1602 PubMed PMID: 26329356.
6. [6] Dal Negro, R.W., Bonadiman, L., Turco, P., Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidiscip Respir Med, 10, 2015, 24 PubMed PMID: 26246895. Pubmed Central PMCID: PMC4525744.
7. [7] Jones, P.W., Nadeau, G., Small, M., Adamek, L., Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med 108 (2014), 129–135 PubMed PMID: 24041746.
8. [8] Chen, W., Thomas, J., Sadatsafavi, M., FitzGerald, J.M., Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med 3 (2015), 631–639 PubMed PMID: 26208998.
9. [9] Cazzola, M., Calzetta, L., Matera, M.G., et al. Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients. Respir Med 109 (2015), 1019–1025 PubMed PMID: 26111914.
10. [10] Hadi, H.A., Zubaid, M., Al Mahmeed, W., et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome. Clin Cardiol 33 (2010), 228–235 PubMed PMID: 20394044.
11. [11] Sung, L.C., Chen, C.I., Fang, Y.A., et al. Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: a population-based cohort study. Vaccine 32 (2014), 3843–3849 PubMed PMID: 24837769.
12. [12] Williams, M.C., Murchison, J.T., Edwards, L.D., et al. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax 69 (2014), 718–723 PubMed PMID: 24473329.
13. [13] Rasmussen, T., Kober, L., Pedersen, J.H., et al. Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokers. Eur Heart J Cardiovasc Imaging 14 (2013), 1159–1166 PubMed PMID: 23639550.
14. [14] O׳Boyle, F., Mediratta, N., Chalmers, J., et al. Long-term survival of patients with pulmonary disease undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 43 (2013), 697–703 PubMed PMID: 23096454.
15. [15] Saleh, H.Z., Mohan, K., Shaw, M., et al. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting. Eur J Cardiothorac Surg 42 (2012), 108–113 Discussion 13. PubMed PMID: 22290913.
16. [16] Gaisl, T., Schlatzer, C., Schwarz, E.I., et al. Coronary artery calcification, epicardial fat burden, and cardiovascular events in chronic obstructive pulmonary disease. PLoS One, 10, 2015, e0126613 PubMed PMID: 26011039. Pubmed Central PMCID: PMC4444203.
17. [17] Park, H.J., Leem, A.Y., Lee, S.H., et al. Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey. Int J Chron Obstruct Pulmon Dis 10 (2015), 1571–1582 PubMed PMID: 26300636. Pubmed Central PMCID: PMC4535560.
18. [18] Higashimoto, Y., Yamagata, T., Maeda, K., et al. Influence of comorbidities on the efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Geriatr Gerontol Int, 2015 PubMed PMID: 26246006.
19. [19] Battaglia, S., Basile, M., Scichilone, N., Bellia, V., Prevalence of co-morbidities and severity of COPD. COPD. 12 (2015), 390–394 PubMed PMID: 25415502.
20. [20] Konecny, T., Park, J.Y., Somers, K.R., et al. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am J Cardiol 114 (2014), 272–277 PubMed PMID: 24878126.
21. [21] Shibata, Y., Watanabe, T., Osaka, D., et al. Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study. Int J Med Sci 8 (2011), 514–522 PubMed PMID: 21897765. Pubmed Central PMCID: PMC3167177.
22. [22] Huang, B., Yang, Y., Zhu, J., et al. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study. J Am Med Dir Assoc 15 (2014), 576–581 PubMed PMID: 24894999.
23. [23] Valk, M.J., Broekhuizen, B.D., Mosterd, A., et al. COPD in patients with stable heart failure in the primary care setting. Int J Chron Obstruct Pulmon Dis 10 (2015), 1219–1224 PubMed PMID: 26170650. Pubmed Central PMCID: PMC4492658.
24. [24] Straburzynska-Migaj, E., Kaluzna-Oleksy, M., Maggioni, A.P., et al. Patients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot) – Polish population. Arch Med Sci 11 (2015), 743–750 PubMed PMID: 26322085. Pubmed Central PMCID: PMC4548022.
25. [25] Ahn, Y.H., Lee, K.S., Park, J.H., et al. Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations. Respiration 90 (2015), 199–205 PubMed PMID: 26278777.
26. [26] Boutou, A.K., Karrar, S., Hopkinson, N.S., Polkey, M.I., Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Respiration 85 (2013), 126–131 PubMed PMID: 22759351.
27. [27] Rasheedy, D., Taha, H.M., Cardiac autonomic neuropathy: the hidden cardiovascular comorbidity in elderly patients with chronic obstructive pulmonary disease attending primary care settings. Geriatr Gerontol Int, 2015 PubMed PMID: 25728036.
28. [28] Chhabra, S.K., De, S., Cardiovascular autonomic neuropathy in chronic obstructive pulmonary disease. Respir Med 99 (2005), 126–133 PubMed PMID: 15672861.
29. [29] Stewart, A.G., Waterhouse, J.C., Howard, P., Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur Respir J 4 (1991), 1207–1214 PubMed PMID: 1804668.
30. [30] Park, S.K., Larson, J.L., The relationship between physical activity and metabolic syndrome in people with chronic obstructive pulmonary disease. J Cardiovasc Nurs 29 (2014), 499–507 PubMed PMID: 24165700. Pubmed Central PMCID: PMC4032377.
31. [31] Mekov, E., Slavova, Y., Tsakova, A., et al. Metabolic syndrome in hospitalized patients with chronic obstructive pulmonary disease. Peer J, 3, 2015, e1068 PubMed PMID: 26157632. Pubmed Central PMCID: PMC4493698.
32. [32] Mahishale, V., Mahishale, A., Patil, B., Sindhuri, A., Eti, A., Screening for diabetes mellitus in patients with chronic obstructive pulmonary disease in tertiary care hospital in India. Niger Med J 56 (2015), 122–125 PubMed PMID: 25838628. Pubmed Central PMCID: PMC4382602.
33. [33] Meteran, H., Backer, V., Kyvik, K.O., Skytthe, A., Thomsen, S.F., Comorbidity between chronic obstructive pulmonary disease and type 2 diabetes: a nation-wide cohort twin study. Respir Med 109 (2015), 1026–1030 PubMed PMID: 26044811.
34. [34] Hersh, C.P., Make, B.J., Lynch, D.A., et al. Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. BMC Pulm Med, 14, 2014, 164 PubMed PMID: 25341556. Pubmed Central PMCID: PMC4216374.
35. [35] Crisafulli, E., Torres, A., Huerta, A., et al. C-reactive protein at discharge, diabetes mellitus and >/= 1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease. COPD 12 (2015), 306–314 PubMed PMID: 25279441.
36. [36] Li, C.I., Li, T.C., Liu, C.S., et al. Extreme values of hemoglobin a1c are associated with increased risks of chronic obstructive pulmonary disease in patients with type 2 diabetes: a competing risk analysis in national cohort of Taiwan diabetes study. Medicine, 94, 2015, e367 PubMed PMID: 25569658. Pubmed Central PMCID: PMC4602831.
37. [37] Carrasco Sanchez, F.J., Recio Iglesias, J., Grau Amoros, J., Complementary treatment of acute heart failure in patients with diabetes, chronic obstructive pulmonary disease or anemia. Med Clin (Barc) 142 (2014), 59–65 PubMed PMID: 24930086.
38. [38] Habib, G., Dar-Esaif, Y., Bishara, H., et al. The impact of corticosteroid treatment on hemoglobin A1C levels among patients with type-2 diabetes with chronic obstructive pulmonary disease exacerbation. Respir Med 108 (2014), 1641–1646 PubMed PMID: 25192601.
39. [39] Hitchings, A.W., Archer, J.R., Srivastava, S.A., Baker, E.H., Safety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitus. COPD 12 (2015), 126–131 PubMed PMID: 25938184.
40. [40] Shen, T.C., Chung, W.S., Lin, C.L., et al. Does chronic obstructive pulmonary disease with or without type 2 diabetes mellitus influence the risk of lung cancer? Result from a population-based cohort study. PLoS One, 9, 2014, e98290 PubMed PMID: 24854189. Pubmed Central PMCID: PMC4031125.
41. [41] Mancini, A., Corbo, G.M., Gaballo, A., et al. Relationship between plasma antioxidants and thyroid hormones in chronic obstructive pulmonary disease. Exp Clin Endocrinol Diabetes 120 (2012), 623–628 PubMed PMID: 23073919.
42. [42] Terzano, C., Romani, S., Paone, G., Conti, V., Oriolo, F., COPD and thyroid dysfunctions. Lung 192 (2014), 103–199 PubMed PMID: 24281671.
43. [43] Schuetz, P., Leuppi, J.D., Bingisser, R., et al. Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol 173 (2015), 19–27 PubMed PMID: 25855628.
44. [44] Schuetz, P., Christ-Crain, M., Schild, U., et al. Effect of a 14-day course of systemic corticosteroids on the hypothalamic–pituitary–adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med, 8, 2008, 1 PubMed PMID: 18221550. Pubmed Central PMCID: PMC2246097.
45. [45] Atlantis, E., Fahey, P., Cochrane, B., Wittert, G., Smith, S., Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open, 3, 2013 PubMed PMID: 23943774. Pubmed Central PMCID: PMC3740247.
46. [46] Kahraman, H., Sen, B., Koksal, N., Kilinc, M., Resim, S., Erectile dysfunction and sex hormone changes in chronic obstructive pulmonary disease patients. Multidiscip Respir Med, 8, 2013, 66 PubMed PMID: 24103191. Pubmed Central PMCID: PMC3844853.
47. [47] Madsen, H., Brixen, K., Hallas, J., Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease – a population-based database study. Clin Respir J 4 (2010), 22–29 PubMed PMID: 20298414.
48. [48] Katsura, H., Kida, K., A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 122 (2002), 1949–1955 PubMed PMID: 12475832.
49. [49] Nuti, R., Siviero, P., Maggi, S., et al. Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO study. Osteoporos Int 20 (2009), 989–998 PubMed PMID: 18931817.
50. [50] Mathioudakis, A.G., Amanetopoulou, S.G., Gialmanidis, I.P., et al. Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial?. Respirology 18 (2013), 147–153 PubMed PMID: 22985270.
51. [51] Sin, D.D., Man, J.P., Man, S.F., The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med 114 (2003), 10–14 PubMed PMID: 12543283.
52. [52] Vrieze, A., de Greef, M.H., Wijkstra, P.J., Wempe, J.B., Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int 18 (2007), 1197–1202 PubMed PMID: 17347789.
53. [53] Coin, A., Sergi, G., Marin, S., et al. Predictors of low bone mineral density in elderly males with chronic obstructive pulmonary disease: the role of body mass index. Aging Male 13 (2010), 142–147 PubMed PMID: 20429721.
54. [54] Jorgensen, N.R., Schwarz, P., Holme, I., et al. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 101 (2007), 177–185 PubMed PMID: 16677808.
55. [55] Ogura-Tomomatsu, H., Asano, K., Tomomatsu, K., et al. Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease. COPD 9 (2012), 332–337 PubMed PMID: 22489911.
56. [56] Wang, F., Liu, J., Zhang, Y., Lei, P., Association of Helicobacter pylori infection with chronic obstructive pulmonary disease and chronic bronchitis: a meta-analysis of 16 studies. Infect Dis (Lond) 47 (2015), 597–603 PubMed PMID: 25797276.
57. [57] Wang, L., Guan, Y., Li, Y., et al. Association between chronic respiratory diseases and helicobacter pylori: a meta-analysis. Arch Bronconeumol 51 (2015), 273–278 PubMed PMID: 24998026.
58. [58] Sze, M.A., Chen, Y.W., Tam, S., et al. The relationship between Helicobacter pylori seropositivity and COPD. Thorax. 70 (2015), 923–929 PubMed PMID: 26024688.
59. [59] Samareh Fekri, M., Hashemi Bajgani, S.M., Rasti, A., Yazdani, R., Mollaie, H.R., Detection of helicobacter pylori in bronchoalveolar lavage of patients with chronic obstructive pulmonary disease by real time polymerase chain reaction. Jundishapur J Microbiol, 8, 2015, e14551 PubMed PMID: 25789128. Pubmed Central PMCID: PMC4350048.
60. [60] Ingebrigtsen, T.S., Marott, J.L., Vestbo, J., et al. Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease. Respirology 20 (2015), 101–107 PubMed PMID: 25297724.
61. [61] Mapel, D.W., Marton, J.P., Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD. Int J Chron Obstruct Pulmon Dis 8 (2013), 127–134 PubMed PMID: 23515180. Pubmed Central PMCID: PMC3600938.
62. [62] Chhabra, S.K., Dash, D.J., Acute exacerbations of chronic obstructive pulmonary disease: causes and impacts. Indian J Chest Dis Allied Sci 56 (2014), 93–104 PubMed PMID: 25230550.
63. [63] Mullerova, H., Shukla, A., Hawkins, A., Quint, J., Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. BMJ Open, 4, 2014, e006171 PubMed PMID: 25524545. Pubmed Central PMCID: PMC4275672.
64. [64] Farland, M.Z., Peters, C.J., Williams, J.D., et al. beta-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations. Ann Pharmacother 47 (2013), 651–656 PubMed PMID: 23585645.
65. [65] Bhatt, S.P., Wells, J.M., Kinney, G.L., et al. beta-Blockers are associated with a reduction in COPD exacerbations. Thorax 71 (2016), 8–14 PubMed PMID: 26283710.
66. [66] Dransfield, M.T., Rowe, S.M., Johnson, J.E., Bailey, W.C., Gerald, L.B., Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 63 (2008), 301–305 PubMed PMID: 17951276.
67. [67] Wang, M.T., Lo, Y.W., Tsai, C.L., et al. Statin use and risk of COPD exacerbation requiring hospitalization. Am J Med, 126, 2013 598–606.e2, PubMed PMID: 23684060.
68. [68] Blamoun, A.I., Batty, G.N., DeBari, V.A., et al. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Int J Clin Pract 62 (2008), 1373–1378 PubMed PMID: 18422598.
69. [69] Ingebrigtsen, T.S., Marott, J.L., Nordestgaard, B.G., et al. Statin use and exacerbations in individuals with chronic obstructive pulmonary disease. Thorax 70 (2015), 33–40 PubMed PMID: 25349333.
70. [70] Burt, M.G., Roberts, G.W., Aguilar-Loza, N.R., et al. Relationship between glycaemia and length of hospital stay during an acute exacerbation of chronic obstructive pulmonary disease. Intern Med J 43 (2013), 721–724 PubMed PMID: 23745995.
71. [71] Baker, E.H., Janaway, C.H., Philips, B.J., et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 61 (2006), 284–289 PubMed PMID: 16449265. Pubmed Central PMCID: PMC2104606.
72. [72] Kasirye, Y., Simpson, M., Mamillapalli, C.K., et al. Association between blood glucose level and outcomes in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. WMJ 112 (2013), 244–249 quiz 50. PubMed PMID: 24511864.
73. [73] Islam, E.A., Limsuwat, C., Nantsupawat, T., Berdine, G.G., Nugent, K.M., The association between glucose levels and hospital outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease. Ann Thorac Med 10 (2015), 94–99 PubMed PMID: 25829959. Pubmed Central PMCID: PMC4375748.
74. [74] Koskela, H.O., Salonen, P.H., Romppanen, J., Niskanen, L., A history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality: a prospective, observational cohort study. BMJ Open, 5, 2015, e006794 PubMed PMID: 25633287. Pubmed Central PMCID: PMC4316436.
75. [75] Koskela, H.O., Salonen, P.H., Niskanen, L., Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease. Clin Respir J 7 (2013), 382–389 PubMed PMID: 23902130.
76. [76] Rinne, S.T., Liu, C.F., Feemster, L.C., et al. Thiazolidinediones are associated with a reduced risk of COPD exacerbations. Int J Chron Obstruct Pulmon Dis 10 (2015), 1591–1597 PubMed PMID: 26300638. Pubmed Central PMCID: PMC4536761.
77. [77] Yasar, Z., Kirakli, C., Cimen, P., et al. Is non-thyroidal illness syndrome a predictor for prolonged weaning in intubated chronic obstructive pulmonary disease patients?. Int J Clin Exp Med 8 (2015), 10114–10121 PubMed PMID: 26309710. Pubmed Central PMCID: PMC4538104.
78. [78] Sarinc Ulasli, S., Bozbas, S.S., Ozen, Z.E., Ozyurek, B.A., Ulubay, G., Effect of thyroid function on COPD exacerbation frequency: a preliminary study. Multidiscip Respir Med, 8, 2013, 64 PubMed PMID: 24079533. Pubmed Central PMCID: PMC3845712.
79. [79] Corbo, G.M., Di Marco Berardino, A., Mancini, A., et al. Serum level of testosterone, dihydrotestosterone and IGF-1 during an acute exacerbation of COPD and their relationships with inflammatory and prognostic indices: a pilot study. Minerva Med 105 (2014), 289–294 PubMed PMID: 24844347.
80. [80] Kythreotis, P., Kokkini, A., Avgeropoulou, S., et al. Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med, 9, 2009, 11 PubMed PMID: 19344528. Pubmed Central PMCID: PMC2670813.
81. [81] Lin, Y.H., Tsai, C.L., Chien, L.N., Chiou, H.Y., Jeng, C., Newly diagnosed gastroesophageal reflux disease increased the risk of acute exacerbation of chronic obstructive pulmonary disease during the first year following diagnosis—a nationwide population-based cohort study. Int J Clin Pract 69 (2015), 350–357 PubMed PMID: 25359162.
82. [82] Takada, K., Matsumoto, S., Kojima, E., et al. Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire. Respir Med 105 (2011), 1531–1536 PubMed PMID: 21454063.
83. [83] Kim, J., Lee, J.H., Kim, Y., et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med, 13, 2013, 51 PubMed PMID: 23927016. Pubmed Central PMCID: PMC3750392.
84. [84] Benson, V.S., Mullerova, H., Vestbo, J., et al. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease. Respir Med 109 (2015), 1147–1154 PubMed PMID: 26166017.
85. [85] Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383 PubMed PMID: 3558716.
86. [86] Almagro, P., Calbo, E., Ochoa de Echaguen, A., et al. Mortality after hospitalization for COPD. Chest 121 (2002), 1441–1448 PubMed PMID: 12006426.
87. [87] Divo, M., Cote, C., de Torres, J.P., et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186 (2012), 155–161 PubMed PMID: 22561964.
88. [88] de Torres, J.P., Casanova, C., Marin, J.M., et al. Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE. Thorax 69 (2014), 799–804 PubMed PMID: 24969641.
89. [89] Budweiser, S., Harlacher, M., Pfeifer, M., Jorres, R.A., Co-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD. COPD 11 (2014), 388–400 PubMed PMID: 24111878.
90. [90] Almagro, P., Soriano, J.B., Cabrera, F.J., et al. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest 145 (2014), 972–980 PubMed PMID: 24077342.
91. [91] Frei, A., Muggensturm, P., Putcha, N., et al. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol 67 (2014), 904–911 PubMed PMID: 24786594.
92. [92] Steer, J., Gibson, J., Bourke, S.C., The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax 67 (2012), 970–976 PubMed PMID: 22895999.
93. [93] Echevarria, C., Steer, J., Heslop-Marshall, K., et al. Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax 71 (2016), 133–140 PubMed PMID: 26769015. Pubmed Central PMCID: PMC4752621.
94. [94] Weinreich, U.M., Thomsen, L.P., Bielaska, B., et al. The effect of comorbidities on COPD assessment: a pilot study. Int J Chron Obstruct Pulmon Dis 10 (2015), 429–438 PubMed PMID: 25750525. Pubmed Central PMCID: PMC4348050. Epub 2015/03/10.
95. [95] Fabbri, L.M., Beghe, B., Agusti, A., COPD and the solar system: introducing the chronic obstructive pulmonary disease comorbidome. Am J Respir Crit Care Med 186 (2012), 117–119 PubMed PMID: 22798411.
96. [96] Almagro, P., Cabrera, F.J., Diez-Manglano, J., et al. Comorbidome and short-term prognosis in hospitalised COPD patients: the ESMI study. Eur Respir J 46 (2015), 850–853 PubMed PMID: 25900375.